Fear memory regulation by the cAMP signaling pathway as an index of reexperiencing symptoms in posttraumatic stress disorder

Hiroaki Hori,Hotaka Fukushima,Taikai Nagayoshi,Rie Ishikawa,Min Zhuo,Fuyuko Yoshida,Hiroshi Kunugi,Kenichi Okamoto,Yoshiharu Kim,Satoshi Kida

DOI: https://doi.org/10.1038/s41380-024-02453-4

IF: 11

2024-02-28

Molecular Psychiatry

Abstract:Posttraumatic stress disorder (PTSD) is a psychiatric disorder associated with traumatic memory, yet its etiology remains unclear. Reexperiencing symptoms are specific to PTSD compared to other anxiety-related disorders. Importantly, reexperiencing can be mimicked by retrieval-related events of fear memory in animal models of traumatic memory. Recent studies revealed candidate PTSD-associated genes that were related to the cyclic adenosine monophosphate (cAMP) signaling pathway. Here, we demonstrate the tight linkage between facilitated cAMP signaling and PTSD by analyzing loss- and gain-of-cAMP signaling effects on fear memory in mice and the transcriptomes of fear memory-activated mice and female PTSD patients with reexperiencing symptoms. Pharmacological and optogenetic upregulation or downregulation of cAMP signaling transduction enhanced or impaired, respectively, the retrieval and subsequent maintenance of fear memory in mice. In line with these observations, integrative mouse and human transcriptome analysis revealed the reduced mRNA expression of phosphodiesterase 4B (PDE4B), an enzyme that degrades cAMP, in the peripheral blood of PTSD patients showing more severe reexperiencing symptoms and the mouse hippocampus after fear memory retrieval. Importantly, more severe reexperiencing symptoms and lower PDE4B mRNA levels were correlated with decreased DNA methylation of a locus within PDE4B , suggesting the involvement of methylation in the mechanism of PTSD. These findings raise the possibility that the facilitation of cAMP signaling mediating the downregulation of PDE4B expression enhances traumatic memory, thereby playing a key role in the reexperiencing symptoms of PTSD patients as a functional index of these symptoms.

biochemistry & molecular biology,neurosciences,psychiatry

What problem does this paper attempt to address?

### Problems the Paper Attempts to Solve This paper primarily explores the mechanisms of the cAMP signaling pathway in post-traumatic stress disorder (PTSD), particularly in the context of re-experiencing symptoms. Specifically, the study reveals the close relationship between the cAMP signaling pathway and PTSD symptoms by analyzing the impact of cAMP signaling on fear memory in mice and the transcriptomic changes in the hippocampus of both PTSD patients and mice. **Main issues include:** 1. **How does the cAMP signaling pathway affect the retrieval and maintenance of fear memory?** - Through pharmacological and optogenetic experiments, the study found that upregulation of cAMP signaling levels enhances the retrieval and maintenance of fear memory, while downregulation weakens these processes. 2. **Which gene expression changes are associated with re-experiencing symptoms in PTSD patients?** - By analyzing the transcriptome of peripheral blood from PTSD patients, the study found that reduced mRNA expression of phosphodiesterase 4B (PDE4B) is associated with more severe re-experiencing symptoms. 3. **Are the gene expression changes in the hippocampus of mice during fear memory retrieval similar to those in human PTSD symptoms?** - By comparing transcriptomic data from humans and mice, the study found that many genes exhibit consistent expression changes in both models, particularly the PDE4B gene. In summary, this paper aims to elucidate the potential mechanisms of the cAMP signaling pathway in PTSD re-experiencing symptoms and explore its potential as a therapeutic target.

Fear memory regulation by the cAMP signaling pathway as an index of reexperiencing symptoms in posttraumatic stress disorder

Reconsolidation/destabilization, extinction and forgetting of fear memory as therapeutic targets for PTSD

Stimulation of Anxiety-Like Behavior via ERK Pathway by Competitive Serotonin Receptors 2A and 1A in Post-Traumatic Stress Disordered Mice.

Involvement of dysregulated hippocampal histone H3K9 methylation at the promoter of the BDNF gene in impaired memory extinction

Fear extinction induced by activation of PKA ameliorates anxiety-like behavior in PTSD mice

Up-Regulation of αCaMKII Impairs Cued Fear Extinction and NMDAR-Dependent LTD in the Lateral Amygdala

Phosphodiesterase-2 inhibitor reverses post-traumatic stress induced fear memory deficits and behavioral changes via cAMP/cGMP pathway

Regulation of fear extinction versus other affective behaviors by discrete cortical scaffolding complexes associated with NR2B and PKA signaling

PET Mapping of Neurofunctional Changes in a Posttraumatic Stress Disorder Model.

Dysfunction of calcium/calmodulin/CaM kinase IIα cascades in the medial prefrontal cortex in post-traumatic stress disorder

Time-course analysis of frontal gene expression profiles in the rat model of posttraumatic stress disorder and a comparison with the conditioned fear model

[Potential PTSD therapeutics targeting 5-HT2C receptors]

Inhibition of Protein Synthesis Attenuates Formation of Traumatic Memory and Normalizes Fear-induced c-Fos Expression in a Mouse Model of Posttraumatic Stress Disorder

Region- and time-dependent gene regulation in the amygdala and anterior cingulate cortex of a PTSD-like mouse model

Activation of a Novel Α 2A AR-spinophilin-cofilin Axis Determines the Effect of Α 2 Adrenergic Drugs on Fear Memory Reconsolidation.

Chemogenetic activation of the mPFC alleviates impaired fear memory extinction in an animal model of PTSD

DCC, a potential target for controlling fear memory extinction and hippocampal LTP in male mice receiving single prolonged stress

Pi4KIIα Regulates Unconditioned Stimulus-Retrieval-Induced Fear Memory Reconsolidation Through Endosomal Trafficking of AMPA Receptors.

Endocannabinoid and neuroplasticity-related changes as susceptibility factors in a rat model of posttraumatic stress disorder

The glucocorticoid receptor-FKBP51 complex contributes to fear conditioning and posttraumatic stress disorder